|
|
Volume 3, Issue 6, December 1996, in PDF
|
|
Article 49: As Prices for CROs Soar, Seller Beware
- Investment banker discusses CRO transaction valuations and the risks for sellers
Article 50: Courting the Elderly
- The fifth part of our series on patient recruitment
- Discusses the importance and challenges of recruiting elderly patients in clinical trials
- Elderly patient recruitment strategies are discussed
Article 51: Acquisitions Market for Investigative Sites Heats Up
Article 52: Sizing Up Sponsors
- Investigative sites rate the best and worst sponsors to work with
- Sites select Merck as top sponsor: say company's infrequent use of CROs is key factor
- Overall, sites give sponsors good - but not great - grades. Survey identifies numerous problem areas in sponsor-site relationships
Price: $59.00
|
|
|